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1. Introduction 
Some antibiotics inhibit protein biosynthesis in
bacteria by acting on elongation factor Tu (EF-Tu) • 
kirromycin (mocimycin) blocks peptide chain elonga- 
tion by preventing the release of EF-Tu from the 
ribosome [1-3], while pulvomycin (labilomycin) 
inhibits the enzymatic binding of aminoacyl-tRNA 
(aa-tRNA) to ribosomes by hindering the formation 
of aa-tRNA • EF-Tu • GTP complex [4]. 
The structure of pulvomycin is similar to that of 
the 5'-substituent of the central tetrahydrofurane 
moiety ofkirromycin (see fig. 1) and preliminary results 
in [4] indicate that both antibiotics bind to the same 
site of EF-Tu. Moreover, hydrolysis of the amide bond 
located in the 5'-substituent of the tetrahydrofurane 
moiety of kirromycin produces two fragments [5] 
which are completely inactive on EF-Tu [3]. These 
observations suggest that this part ofkirromycin struc- 
ture could be responsible for the action on EF-Tu. 
Periodate oxidation of mocimycin (kirromycin) 
results in the formation of an aldehyde which was 
purified as its 2,4-dinitrophenylhydrazone [5]. The 
fragment, named fragment 7, virtually corresponds to
the entire 5'-substituent of the central tetrahydrofurane 
moiety of kirromycin (fig.l). 
Here, I have investigated the activity of fragment 7
in the in vitro system ofEscher ich ia  coli  and found 
that this fragment can promote all the effects of the 
intact antibiotic on EF-Tu reactions. 
2. Materials and methods 
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Fig.1. Structure of kirromycin (mocimycin), fragment 7 and 
pulvomycin (from top to bottom). The 5 '-and 2'-substituents 
of the tetrahydrofurane moiety of kirromycin correspond to
the parts of the antibiotic structure that are located in the 
figure at the left and at the right side of the tetrahydrofurane 
ring, respectively. 
2.1. Ant ib iot ics  
Kirromycin was a gift of Dr H. Wolf, University of 
Tubingen and fragment 7was kindly donated by Dr 
C. Vos, Research Labs. of Gist-Brocades, Delft. The 
high purity of fragment 7was confirmed by thin-layer 
chromatography analysis on precoated plates (silica 
gel 60 F-254, Merck, Darmstadt). Development of
the chromatograms with 3 different solvent systems 
resulted in the migration of the product as a single 
spot of UV-absorbing material without evidence of 
contaminants. Moreover, the in vitro biological activity 
of the fragment was not affected by its reisolation by 
preparative thin-layer chromatography on silica gel 
with the solvent system chloroform-methanol- 
ethanol (48:1:1). This ruled out the possibility that 
fragment 7(R F 0.48) could be trace-contaminated by 
kirromycin (R F 0.10) or by kirromycin 2,4-dinitro- 
phenylhydrazone (R F 0.19). 
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2.2. Other materials 
NH4Cl-washed ribosomes, homogeneous elonga- 
tion factor G (EF-G) and T (EF-T, the 1 : 1 complex 
of elongation factors Tu and Ts), crystalline EF-Tu • 
GDP and phenylalanyl-tRNA synthetase, all from 
E. coli B, were prepared as reported [2,6-8]. EF-Tu 
(90-95% GDP-free) was obtained by EDTA treatment 
of EF-Tu - GDP according to [9]. [14C]Phe-tRNA~ 
(65% pure, 487 Ci/mol) and [7-a2P]GTP were pre- 
pared as in [10,11]. 
E. coli. The inhibition of the polymerization reaction 
by the fragment required its use at concentrations 
much higher than those needed by the intact antibiotic. 
As judged from the respective concentrations causing 
50% inhibition (10 -4 M and 2.3 X 10 -7 M) the affinity 
of fragment 7 for EF-Tu was lower than that of kirro- 
mycin by nearly 3 orders of magnitude. Because of its 
poor solubility, fragment 7could be tested only up to 
0.3 mM at which the elongation reaction was 80% 
inhibited. 
2.3. Assays 
All reactions were carried out in TNM 7 buffer 
(40 mM Tris-HC1, pH 7.8; 5 0 mM NH4C1; 7 mM MgC12; 
2 mM dithiothreitol). Reaction mixtures also contained 
0.3-1.5% ethanol carried over with the antibiotics. In 
each experiment the concentration ofethanol was kept 
constant in all samples including the control without 
antibiotics. Assays of poly(phenylalanine) synthesis, 
GTP hydrolysis, binding of Phe-tRNA to poly(U) - 
ribosomes and formation of EF-Tu • GTP and Phe- 
tRNA • EF-Tu • GTP complexes were performed as 
in [1-3,8,12]. Details of the experimental conditions 
are given in the legends to table and figures. 
3. Results 
3.1. Poly( U)-directed poly(phenylalanine ) syn thesis 
As illustrated in fig.2, fragment 7 inhibited poly- 
(phenylalanine) synthesis in the in vitro system of 
3.2. EF-Tu~tependent G TPase activity 
The hydrolysis of GTP that takes place during the 
enzymatic binding of aa-tRNA to ribosomes requires 
EF-Tu, aa-tRNA, ribosomes and the appropriate mes- 
senger RNA [ 13]. In the presence ofkirromycin, EF-Tu 
can catalyze the reaction even in the absence of the 
other components [ 1-3]. This kirromycin-induced 
GTPase activity of EF-Tu is low at the ionic condi- 
tions used in this work, but it can be stimulated up to 
3- and 15-fold by the addition of Phe-tRNA and ribo- 
somes, respectively [ 1-3,14]. By contrast, pulvomycin 
inhibits the reaction even in the presence of all com- 
ponents [4]. 
Fragment 7was found to have the same effect of 
kirromycin on EF-Tu GTPase activity. This is illus- 
trated in fig.3 for the system containing EF-Tu and 
ribosomes. Also in this case, the maximal activity of 
the intact antibiotic was not reached by fragment 7
because of its low solubility and poor affinity for EF-Tu. 
Results equivalent to those depicted in fig.3 were 
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Fig.2. Inhibition of poly(phenylalanine) synthesis by fragment 
7 and kitromycin. Reaction mixtures contained in 75 pl TNM 
7 buffer 25 pmol ribosomes, 5/~g poly(U), 35 pmol EF-G, 
9 pmol EF-T, 10 pmol phenylalanyl-tRNA synthetase, 
Phe 14 60 pmol tRNA ,180 pmol [ C]phenylalanine (486 Ci] 
mol), 75 nmol ATP and 15 nmol GTP. Reaction was for 
10 min at 30°C. Samples were analyzed for phenylalanine 
polymerized as in [8]. Values axe given as % of the amount 
of phenylalanine incorporated in the control without antibio- 
tics (32.5 pmol): plus kirromycin (o); plus fragment 7 (e). 
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Fig.3. Activation of uncoupled EF-Tu GTPase activity by 
fragment 7 and kittomycin. Reaction mixtures contained in 
75 #1 TNM 7 buffer 40 pmol ribosomes, 9 pmol EF-T, 
310 pmol [7-32P]GTP (510 Ci/mol) and kixromycin (o) 
or fragment 7 (e). After 15 min at 30°C, samples were 
analyzed for 32P i liberated [7 ]. Values axe given as % of the 
amount of GTP hydrolyzed in the presence of the optimal 
concentration of kirtomycin (41.5 pmol). In the absence of 
antibiotics the amount of GTP hydrolyzed was 0.3 pmol." 
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obtained in the systems containing EF-Tu alone or 
EF-Tu plus Phe-tRNA (not shown). 
3.3. Interaction of EF-Tu with GTP and aminoacyl- 
tRNA 
In the absence of aa-tRNA the affinity of EF-Tu 
for GDP is almost 3 orders of magnitude higher than 
that for GTP [9,13]. Kirromycin and pulvomycin 
dramatically increase the affinity of EF-Tu for GTP: 
in their presence free GTP can displace GDP bound to 
EF-Tu [ 1,2,9]. Fragment 7was also found to promote 
the GTP-GDP exchange reaction (fig.4). At 0.1 mM 
the fragment caused 44% of the exchange observed in 
the presence of 10 #M kirromycin, an effect equivalent 
to that observed in the induction of EF-Tu GTPase 
(see fig.3). Moreover, fragment 7was found to stimu- 
late the exchange of free GDP with EF-Tu-bound GDP 
like kirromycin [9]. 
The EF-Tu • GTP complexes formed in the presence 
or the absence of kirromycin, but not that formed in 
the presence ofpulvomycin, bind aa-tRNA [ 1,2,4,9,13]. 
The EF-Tu - GTP complex formed in the presence of 
fragment 7 is able to bind aa-tRNA as indicated by its 
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Fig.4. Effect of fragment 7and kirromycin on the exchange 
of free GTP with GDP bound to EF-Tu. Reaction mixtures 
contained in0.4 mol TNM 7 buffer 80 pmol EF-Tu - GDP, 
250 pmol [3,-32P]GTP (360 Ci/mol) and kirromycin or frag- 
ment 7 as indicated. The exchange r action was carried out 
at 0°C and started by the addition of GTP. At the indicated 
times, the amount of EF-Tu - GTP complex formed was 
determined on 90/al aliquots [1 ]: without antibiotics (o); 
with 10 #M kirromycin (o); with 0.1 mM fragment 7(e). 
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Fig.5. Ability of EF-Tu • GTP complexes formed in the pres- 
ence of fragment 7and kirromycin to bind Phe-tRNA. 
EF-Tu - GTP complexes were prepared by incubation of
200 pmol EF-Tu • GDP with 610 pmol [-r-32P]GTP (330 Ci/ 
mol) in the presence of 15 ~tM kirromycin (o) or 0.15 mM 
fragment 7(e) for 30 min at 24°C and in a final volume of 
0.52 ml TNM 7 buffer. Then, 80 ~1 aliquots of the two 
reaction mixtures were added to 40/A TNM 7 buffer con- 
taining Phe-tRNA as indicated. After 10 min at 0°C samples 
were analyzed for the amount of EF-Tu - GTP complex 
retained on nitrocellulose f'flters (miUipore HAPW 0.45 urn). 
The loss of EF-Tu - GTP complex from f'flter measures the 
amount of Phe-tRNA - EF-Tu complex formed. 
release from nitrocellulose filters upon addition of 
Phe-tRNA (fig.5) [12]. 
3.4. EF-Tu-directed binding of aminoacyl-tRNA to 
ribosomes 
In the presence of kirromycin, EF-Tu can promote 
the binding ofaa-tRNA to the ribosomal A site even 
without GTP, while pulvomycin completely blocks the 
reaction [1,3,4]. 
EF-Tu and EF-Tu • GDP became able to Promote 
the binding of Phe-tRNA to poly(U) • ribosomes in 
the presence of 0.1 mM fragment 7(table 1). Little 
stimulation of the reaction was observed with EF-T 
(EF-Tu • EF-Ts complex). This indicates that EF-Ts 
interferes with the binding of fragment 7 to EF-Tu. 
A competition between kirromycin and EF-Ts for the 
interaction with EF-Tu has been observed [2,15]. In 
the experiment of table 1, kirromycin could stimulate 
the binding reaction with EF-T because the antibiotic 
was used at a concentration at which it can displace 
EF-Ts from EF-Tu. 
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Table 1 
Effect of fragment 7and kirromycin on the EF-Tu-directed binding of Phe-tRNA 
to poly(U) - ribosomes 
Experimental 
conditions 
[14C]Phe-tRNA bound to ribosomes (pmol) 
Control + Fragment 7 + Kirromycin 
+ EF-Tu 0.1 2.5 4.6 
+ EF-Tu • GDP 0.2 2.6 4.8 
+ EFoTu - EF-Ts 0.0 0.5 4.3 
+ EF-Tu • EF-Ts + GTP 5.8 5.2 5.1 
Reaction mixtures contained 25 pmol ribosomes, 5 tzg poly(U), 54 pmol tRNA Phe, 
12 pmol [14C]Phe-tRNA and, when indicated, 40 pmol EF-Tu, EF-T or EF-Tu - 
GDP, 0.2 nmol GTP, 7.5 nmol fragment 7or 0.75 nmol kirromycin. Ribosomes 
were preincubated with poly(U) and tRNA Phe in order to fill the P site prior to 
the addition of the other components [1 ]. The reaction mixtures (75 ~1) in TNM 
buffer containing 10 mM MgCI~ were incubated for 10 min at 30°C and then 
analyzed for the amount of Phe-tRNA bound to ribosomes [ 1 ]. All values are cor- 
rected for the amount of Phe-tRNA bound non-enzymatically to ribosomes in the 
absence of EF-Tu (2.1 pmol) 
4. Discussion 
The ability of fragment 7 to promote all the effects 
of kirromycin indicates that only the part of the anti- 
biotic structure which corresponds tothe 5'-substituent 
of the central tetrahydrofurane moiety is directly 
responsible for the action on EF-Tu. The following 
observations suggest hat the main and possibly exclu- 
sive role of the rest of the antibiotic structure is to 
increase the antibiotic affinity for the elongation fac- 
tor: 
(i) Fragment 4a of mocimycin (kirromycin) which 
contains both the tetrahydrofurane ring and its 
2'-substituent [5] is completely inactive [3]; 
(ii) Chemical modifications of the acid hydroxyl and 
cheto functions located in the 2'-substituent do 
not affect he mode of action of kirromycin, but 
lower its affinity for EF-Tu (G. C., unpublished); 
(iii) Fragment 7interacts very weakly with EF-Tu (in 
this case, however, the presence of the 2,4-dini- 
trophenylhydrazone group could also contribute 
to reduce the affinity of the fragment for EF-Tu). 
The finding that kirromycin acts on EF-Tu with 
the part of its structure which is related to pulvomycin 
and the results in [4] indicating that these antibiotics 
compete for the interaction with EF-Tu suggest a
common site of action on the elongation factor. If 
this assumption is correct, the distinct effects ofkir- 
romycin and pulvomycin on EF-Tu activity should 
depend on the ability of these antibiotics to promote 
different conformational changes of the same EF-Tu 
site presumably as a consequence of the differences 
between the structure of pulvomycin and that of the 
5'-substituent of the tetrahydrofurane moiety of kir- 
romycin. 
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